Top compounds associated with response to ARL16


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.00035 1
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC -0.00024 1
mRNA CIL56 CTRPv2 pan-cancer AAC 0.00016 1
mRNA CCT007093 GDSC1000 pan-cancer AAC 2.4e-06 1
Download CSV